Co-Diagnostics adopts change-in-control severance plan; CEO 3x, CFO 2x multipliers

Co-Diagnostics, Inc.

Board approved Change in Control Severance Plan for select management; CEO Dwight Egan gets 3x multiplier, CFO Brian Brown gets 2x.
Severance benefit = multiplier times (base salary + greater of target bonus or avg of three highest actual bonuses).
Benefits triggered by termination without cause or for good reason within 2 years after a change in control.
Payment is lump sum after signing separation agreement; subject to Section 409A limitations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.